CAT No: CP27935
CAS No:222725-35-1
Synonyms/Alias:Fmoc-N-(allyl)-glycine;222725-35-1;N-(((9H-Fluoren-9-yl)methoxy)carbonyl)-N-allylglycine;Fmoc-DL-Gly(allyl)-OH;Glycine, N-[(9H-fluoren-9-ylmethoxy)carbonyl]-N-2-propenyl-;2-[9H-fluoren-9-ylmethoxycarbonyl(prop-2-enyl)amino]acetic acid;{[(9H-FLUOREN-9-YLMETHOXY)CARBONYL](PROP-2-EN-1-YL)AMINO}ACETIC ACID;MFCD17976766;N-Fmoc-N-allyl-glycine;SCHEMBL490627;DTXSID20442903;XIA72535;Fmoc-N-(allyl)-glycine, AldrichCPR;AKOS015912121;HY-W036352;BS-25396;DA-53332;CS-0089995;EN300-81266;D74905;Z1227753787;2-({[(9H-fluoren-9-yl)methoxy]carbonyl}(prop-2-en-1-yl)amino)acetic acid;108-527-9;
1. Immune-awakening Saccharomyces-inspired nanocarrier for oral target delivery to lymph and tumors
3. Emerging applications of nanotechnology for diagnosis and therapy of disease: a review
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.